ArticleIndian journal of ophthalmology2026
Outcomes of higher-order aberration correction in relation to optical zone size after Phorcides-planned laser in situ keratomileusis in Indian Eyes.
Article in Indian journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the influence of additional ablation (Abl-max) on higher-order aberrations (HOAs), particularly corneal coma, following Phorcides-planned topography-guided laser in situ keratomileusis (LASIK) in an Indian population.
methodsWe analyzed 161 eyes of 83 patients undergoing Phorcides-planned topography-guided LASIK between June 2022 and June 2023. Assessments at baseline and 1, 3, and 6 months included distance visual acuity, manifest refraction, Pentacam tomography, and iTrace aberrometry. Abl-Max was stratified into quartiles (Q1-4) and deciles (Q1-10). The primary outcomes were total HOAs and corneal coma (KCm) at 6 months. Logistic, linear, and decision tree regression models identified predictors of low coma (lowest quartile of KCm6 ≤ 0.037m).
resultsQ1 of Abl-max eyes had higher baseline myopia (-4.36 ± 1.62D vs. -2.76 ± 1.79D), and fewer were treated with 6.5 mm Optic Zone (OZ) (31.2% vs. 67.6%) compared to Q4 (both P < 0.001). At 6 months, KCm6 was higher in Q1 (0.11 ± 0.10 vs. 0.07 ± 0.06 µm in Q4, P = 0.015). The mean postoperative binocular uncorrected vision was 20/17 in both quartiles. Logistic regression showed that lower myopia (OR 1.51, 95% CI 1.21-1.92; P = 0.0004) and 6.5 mm OZ (OR 4.24, 95% CI 0.92-20.38; P = 0.066) predicted low coma. A decision tree model achieved AUROC 0.77, with the lowest coma in eyes with mild-moderate myopia (-2D to -3D) and 6.5 mm OZ.
conclusionPhorcides-planned LASIK permits safe deeper ablations with excellent vision, but coma induction persists, especially in higher myopes (>-4D) with 6.0 mm OZ. Larger OZs (6.5 mm) may optimize coma outcomes where residual stromal thickness permits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.